BioSpace News Archive

Parallax Health Sciences, Inc. (OTCQB: PRLX) (''Parallax’’ or the ''Company’’), an outcome-driven connected healthcare company, today announced its wholly owned subsidiary Parallax Health Management, Inc. focused on Remote Patient Monitoring (“RPM”) has the Health Insurance Portability and Accountability Act (“HIPAA”) compliant, proprietary and patented Good Health Outcomes™ platform now available for doctors and their patients within the United States

Company to host conference call today, March 12, 2020, at 8:00 a.m. ET providing an overview of 2019 and 2020 highlights.

- Conference Call and Webcast Today at 8:30 a.m. EDT / 5:30 a.m. PDT -

- On track to report progression free survival and overall survival data from triple combination arm of ongoing COMBAT/KEYNOTE-202 Phase 2a trial in mid-2020 -

IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC QB: IPATF), following its announcement to develop innovative treatments against the new coronavirus, SARS-CoV-2, unveils its unique approach utilizing PolyTope mAb TherapyTM, enabled by IPA’s diverse discovery platforms and artificial intelligence capabilities with their partner, EVQLV, Inc., in the development of a universal COVID-19 therapy.

NuVera Medical, Inc., a portfolio company of Shifamed LLC, has been awarded the “Top 25 Cardiac Imaging Leaders 2020" honor from Cardiology2.0 Magazine as recognition for the impact the company is making in the cardiac imaging space.

Company to waive member cost-sharing, cover screening costs for Medicaid, Medicare and Marketplace members

Provention Bio, Inc.today report financial results for fourth quarter and full year ended December, 2019.

Aldeyra Therapeutics today reported financial results for the year ended December 31, 2019.

Company recognizes World Kidney Day and National Kidney Month - Aurinia Pharmaceuticals Inc.